Literature DB >> 2862622

Angioimmunoblastic lymphadenopathy, sulphasalazine exposure and villous atrophy.

M A Smith, P R Steele, G R Youngs.   

Abstract

A woman with inflammatory lesions in the terminal ileum was treated with sulphasalazine. Nine months later she developed angioimmunoblastic lymphadenopathy and was found to have intestinal villous atrophy. Her systemic illness partially responded to oral steroids but a gluten free diet restored clinical and biochemical well being coincident with a return of her villous pattern.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2862622      PMCID: PMC2418216          DOI: 10.1136/pgmj.61.714.337

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  6 in total

1.  Angio-immunoblastic lymphadenopathy with dysproteinaemia.

Authors:  G Frizzera; E M Moran; H Rappaport
Journal:  Lancet       Date:  1974-06-01       Impact factor: 79.321

2.  Glandular fever-like illness associated with sulphasalazine.

Authors:  D L Carr-Locke; M Ali
Journal:  Postgrad Med J       Date:  1982-10       Impact factor: 2.401

3.  Diuretics.

Authors:  L E Earley
Journal:  N Engl J Med       Date:  1967-04-27       Impact factor: 91.245

4.  Angio-immunoblastic lymphadenopathy: report of ten cases and review of the literature.

Authors:  M H Cullen; A G Stansfeld; R T Oliver; T A Lister; J S Malpas
Journal:  Q J Med       Date:  1979-01

5.  Letter: Immunoblactic lymphadenopathy associated with phenytoin (diphenylhydantoin).

Authors:  M J Lapes; R J Vivacqua; K Antoniades
Journal:  Lancet       Date:  1976-01-24       Impact factor: 79.321

6.  Prednisone in treatment of allergen-associated angio-immunoblastic lymphadenopathy.

Authors:  S R Newcom; M E Kadin
Journal:  Lancet       Date:  1979-03-03       Impact factor: 79.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.